Navigation Links
Amylin Announces Preliminary Results of Annual Meeting of Stockholders
Date:5/27/2009

SAN DIEGO, May 27 /PRNewswire-FirstCall/ -- Amylin Pharmaceuticals, Inc. (Nasdaq: AMLN) today announced that, based on a preliminary vote count provided by its proxy solicitor, shareholders voted to elect at least 10 of the Company's nominees, including its two new independent nominees, Paul N. Clark and Paulo F. Costa, to Amylin's Board of Directors at the Company's Annual Meeting of Stockholders held today. The Company believes that no more than two of the five dissident nominees (one independent nominee from Eastbourne Capital Management, L.L.C. and one nominee from Carl Icahn) have been elected to Amylin's Board. Additionally, Mr. Icahn's proposal to reincorporate the Company from Delaware to North Dakota has been defeated.

The Company issued the following statement:

We appreciate the consideration and support of our shareholders, as well as the valuable insights offered to our Board and management team over the past several months. Today's outcome affirms that shareholders have confidence in the Company's plan to build value in 2009 and beyond, having apparently elected only two of the five dissident nominees.

We remain deeply committed to building long-term value for all of our shareholders, especially through the anticipated launch of exenatide once weekly, our investigational therapy that has the potential to significantly advance the treatment of type 2 diabetes. We thank all of our Directors for their tremendous commitment and contributions to Amylin. Our Board and management team will work with the new Directors to continue to bring transformational medicines to patients and maximize shareholder value.

IVS Associates, Inc., the independent Inspector of Elections, has indicated that it expects to issue a preliminary tabulation of the vote results early next week. Final results of t
'/>"/>

SOURCE Amylin Pharmaceuticals, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine news :

1. Amylin Pharmaceuticals to Webcast Corporate Overview During 43rd Annual Meeting of the European Association for the Study of Diabetes
2. Amylin Pharmaceuticals to Webcast Third Quarter Results
3. Amylin Pharmaceuticals to Webcast Conference Call
4. Amylin Pharmaceuticals to Present at Research & Development Day
5. Xenome Enters Into Joint Research Collaboration to Discover Novel Peptide Therapeutics with Amylin Pharmaceuticals
6. Amylin Pharmaceuticals Reports 2007 Financial Results
7. Amylin Pharmaceuticals Reports First Quarter Financial Results
8. Amylin Pharmaceuticals Diabetes Drug Byetta the Focus of California Lawsuit
9. Lilly and Amylin Set Date and Time for Conference Call
10. Amylin Pharmaceuticals to Present at Lazard Capital Markets Healthcare Conference
11. Amylin, Lilly Update on FDA Review of BYETTA(R) (exenatide) Injection Monotherapy Submission
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/27/2014)... In order to enable people to adapt to the ... way to avoid touching a toilet seat and/or lid while ... of the patent-pending Toilet Tamer, a device that enables a ... in a more sanitary manner. It avoids direct contact with ... promotes good hygiene and peace of mind. The portable device ...
(Date:11/27/2014)... 27, 2014 Now that Thanksgiving is ... officially launched, Emassagechair.com has announced its eagerly ... Event. , Negotiating on behalf of their customers, ... chair brands, Emassagechair.com has generated significant buzz in the ... biggest discounts yet. , Shoppers are excited for significant ...
(Date:11/27/2014)... VogueQueen.com is making every effort to offer more ... As the premier online supplier of elegant special occasion ... a huge selection of sexy prom dresses today. In ... providing many beautiful styles in its product line. Click ... prices. , “VogueQueen.com hopes to provide a truly unique ...
(Date:11/27/2014)... Developers and plugin specialist of Final Cut ... taking FCPX to the next level. , “ProPip allows users ... clicks of a mouse,” said Christina Austin, CEO of Pixel ... will appreciate.” , With ProPip users can show off their ... endless. ProPip is great for commentaries, news casting, and more. ...
(Date:11/27/2014)... November 27, 2014 HealthPostures, a ... ergonomics equipment , has announced that it has ... Office Environments. The partnership will put HealthPostures' products ... location. , In addition to having its products ... partnership promotes HealthPostures' products with the business decision ...
Breaking Medicine News(10 mins):Health News:Emassagechair.com is Excited to Announce Their Biggest Discount Event of the Year, Starting the Day After Thanksgiving and Lasting Through The Holiday Weekend. 2Health News:Emassagechair.com is Excited to Announce Their Biggest Discount Event of the Year, Starting the Day After Thanksgiving and Lasting Through The Holiday Weekend. 3Health News:Emassagechair.com is Excited to Announce Their Biggest Discount Event of the Year, Starting the Day After Thanksgiving and Lasting Through The Holiday Weekend. 4Health News:A New Collection of Sexy Prom Dresses Has Been Released by the Reliable Online Supplier VogueQueen.com 2Health News:Pixel Film Studios released ProPip plugin Exclusively for Final Cut Pro X 2Health News:Pixel Film Studios released ProPip plugin Exclusively for Final Cut Pro X 3Health News:Ergonomics Manufacturer Announces New Partnership with Office Supply Dealer 2
... and Development, RESTON, Va., Feb. 4 ... that Donald W. Hackett, chief executive,officer, has left ... Bruce Roberts, RPh, executive vice president and ... chairman of Mirixa,s board of,directors, expressed appreciation for ...
... May Help Protect Your Heart, LANSING, Mich., Feb. ... mantras for promoting heart-health during February,American Heart Month. But ... red to protect our hearts. Americans are encouraged to ... first-ever National,Eat Red Week, Feb. 4-10., Why eat ...
... OTTAWA, Feb. 4 Sports and,nutritional product ... http://www.naturalnutritioninc.com primary operating subsidiary,InterACTIVE Nutrition, ... increase,in 2007 revenues over the calendar year ... (CDN) versus 2007 unaudited revenues of $17,460,780,(CDN)., ...
... Simcere Pharmaceutical,Group (NYSE: SCR ), a leading ... anti-cancer pharmaceuticals in the rapidly,growing China market, announced ... quarter results on Tuesday, March 4, 2008 before ... executive officer, Jinsheng Ren, and,chief financial officer, Frank ...
... SAN ANTONIO, Feb. 3 Noticing a few extra hairs ... trying to conceal areas of,thinning hair rather than a fashion ... promoting hair growth? If you answered,yes to any of these ... some form of hair loss. But to whom should you ...
... prove anecdotes that canines can smell dangerous drops in blood ... researchers hope to prove that a dog,s keen sense of ... sugar levels of diabetics. , Canines have already shown themselves ... the physically disabled with daily tasks. , But researchers at ...
Cached Medicine News:Health News:Mirixa Corporation Announces Leadership Change 2Health News:Celebrate American Heart Month by Eating Red 2Health News:Celebrate American Heart Month by Eating Red 3Health News:Natural Nutrition Operating Subsidiary Reports Record 29% Increase in Revenues for 2007 of $17,460,000 2Health News:Simcere Pharmaceutical Group to Announce Fourth Quarter 2007 Earnings on Tuesday, March 4, 2008 2Health News:Don't Let Hair Loss Tangle You Up: Dermatologists Can Identify Common Hair Disorders and Offer Solutions 2Health News:Don't Let Hair Loss Tangle You Up: Dermatologists Can Identify Common Hair Disorders and Offer Solutions 3Health News:Don't Let Hair Loss Tangle You Up: Dermatologists Can Identify Common Hair Disorders and Offer Solutions 4Health News:Don't Let Hair Loss Tangle You Up: Dermatologists Can Identify Common Hair Disorders and Offer Solutions 5Health News:Don't Let Hair Loss Tangle You Up: Dermatologists Can Identify Common Hair Disorders and Offer Solutions 6Health News:Dogs Could Be a Diabetic's Best Friend 2Health News:Dogs Could Be a Diabetic's Best Friend 3Health News:Dogs Could Be a Diabetic's Best Friend 4
(Date:11/26/2014)... November 25, 2014 According ... by Power Source (Electric, Battery, Pneumatic), by Product ... Burr, Cart), by Application (Orthopedic, ENT, Oral, Thoracic, ... MarketsandMarkets, the global Powered Surgical Instruments Market is estimated ... in 2014 and is expected to grow at ...
(Date:11/26/2014)... 2014 Nanomix Inc., (Nanomix), a ... of mobile diagnostic tests to enable earlier ... pre-hospital settings, today announced it has received ... certification was awarded by the British Standards ... certification bodies. ISO 13485:2003 ...
(Date:11/26/2014)... THOUSAND OAKS, Calif. and LONDON ... AMGN ) and AstraZeneca (NYSE: AZN ) today ... trial evaluating two doses of brodalumab in more than 1,800 ... compared with both Stelara ® (ustekinumab) and placebo at ... the brodalumab weight-based analysis group were each shown to be ...
Breaking Medicine Technology:Powered Surgical Instruments Market Worth $2.1 Billion by 2019 2Powered Surgical Instruments Market Worth $2.1 Billion by 2019 3Powered Surgical Instruments Market Worth $2.1 Billion by 2019 4Nanomix Receives ISO 13485:2003 Certification 2Amgen And AstraZeneca Announce Positive Results From Third And Final Pivotal Phase 3 Study Of Brodalumab In Patients With Moderate-To-Severe Plaque Psoriasis 2Amgen And AstraZeneca Announce Positive Results From Third And Final Pivotal Phase 3 Study Of Brodalumab In Patients With Moderate-To-Severe Plaque Psoriasis 3Amgen And AstraZeneca Announce Positive Results From Third And Final Pivotal Phase 3 Study Of Brodalumab In Patients With Moderate-To-Severe Plaque Psoriasis 4Amgen And AstraZeneca Announce Positive Results From Third And Final Pivotal Phase 3 Study Of Brodalumab In Patients With Moderate-To-Severe Plaque Psoriasis 5Amgen And AstraZeneca Announce Positive Results From Third And Final Pivotal Phase 3 Study Of Brodalumab In Patients With Moderate-To-Severe Plaque Psoriasis 6Amgen And AstraZeneca Announce Positive Results From Third And Final Pivotal Phase 3 Study Of Brodalumab In Patients With Moderate-To-Severe Plaque Psoriasis 7Amgen And AstraZeneca Announce Positive Results From Third And Final Pivotal Phase 3 Study Of Brodalumab In Patients With Moderate-To-Severe Plaque Psoriasis 8Amgen And AstraZeneca Announce Positive Results From Third And Final Pivotal Phase 3 Study Of Brodalumab In Patients With Moderate-To-Severe Plaque Psoriasis 9Amgen And AstraZeneca Announce Positive Results From Third And Final Pivotal Phase 3 Study Of Brodalumab In Patients With Moderate-To-Severe Plaque Psoriasis 10
... N.J., Dec. 22, 2011  Ikaria, Inc. announced today that ... DS drug-delivery systems related to a fretting corrosion.  This ... direction of the U.S. Food and Drug Administration (FDA).  ... a reasonable likelihood of serious adverse health consequences or ...
... 2011 ViroPharma Incorporated (NASDAQ: VPHM ) today ... acquire Meritage Pharma, Inc., a private company based in San ... a treatment for eosinophilic esophagitis (EoE), a chronic inflammatory disorder ... initial $7.5 million, and has agreed to provide Meritage up ...
Cached Medicine Technology:Ikaria® Issues Notice of Completed Remediation for INOMAX® DS Drug-delivery System 2Ikaria® Issues Notice of Completed Remediation for INOMAX® DS Drug-delivery System 3ViroPharma Purchases Exclusive Option to Acquire Meritage Pharma 2ViroPharma Purchases Exclusive Option to Acquire Meritage Pharma 3ViroPharma Purchases Exclusive Option to Acquire Meritage Pharma 4ViroPharma Purchases Exclusive Option to Acquire Meritage Pharma 5ViroPharma Purchases Exclusive Option to Acquire Meritage Pharma 6ViroPharma Purchases Exclusive Option to Acquire Meritage Pharma 7
...
EDM Ventricular Drainage Kit, with Drip Chamber with and without Bioglide are fabricated of radiopaque (barium impregnated) silicone tubing, and are packaged with stainless steel stylets inserted in ...
Lumbar External Drainage System (LED) with Touhy needle is indicated for temporary access to the Lumbar Subarachnoid region as a means of draining cerebral spinal fluid (CSF) in order to reduce incre...
Monitorr ICP external CSF drainage and monitoring system with patient line one way valve....
Medicine Products: